You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study

Article info

Article menu
Original research
Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study

Authors

  • Belinda Cruse Neurology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, AustraliaDepartment of Medicine (RMH), The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Thanuja Dharmadasa Neurology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Elise White Neurology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Callum Hollis Neurology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Andrew Evans Neurology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, AustraliaDepartment of Medicine (RMH), The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Sifat Sharmin Department of Medicine (RMH), The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Tomas Kalincik Neurology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, AustraliaDepartment of Medicine (RMH), The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Lynette Kiers Neurology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, AustraliaDepartment of Medicine (RMH), The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Belinda Cruse; belinda.cruse{at}mh.org.au
View Full Text

Citation

Cruse B, Dharmadasa T, White E, et al
Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study
BMJ Neurology Open 2022;4:e000328. doi: 10.1136/bmjno-2022-000328

Publication history

  • Received June 11, 2022
  • Accepted August 11, 2022
  • First published September 5, 2022.
Online issue publication 
September 05, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.